Nicolai Tangen
AKO Capital
AKO Capital Portfolio 13F
Nicolai Tangen Holdings Activity
- Portfolio value:
- $6.37B≈ (+$645M≈)
- Previous value:
- $5.73B≈
- # of changes:
- 27
- New positions:
- 3
- Reported for:
- 30 Sep 2020 (Q3)
- Latest filing date:
- 02 Nov 2020
AKO Capital has disclosed a total of 27 changes to the portfolio in the (2020 Q3) SEC report(s): increased the number of shares of 15, bought 3 totally new, decreased the number of shares of 7 and completely sold out 2 position(s).
What stocks did Nicolai Tangen buy in 2020 Q3?
During 2020 Q3 Nicolai Tangen has bought 18 securities out of which top 5 purchases (by % change to portfolio) were (EBAY) eBay Inc (added shares +6.97%), (V) Visa Inc, CL-A (added shares +1.90%), (EL) Estee Lauder Companies Inc (added shares +1.57%), (PG) Procter & Gamble Company (added shares +14.04%) and (NKE) Nike Inc (added shares +32.57%).
In the 2020 Q3 report(s) the following changes have been made to the top investments: (LIN) Linde plc Ordinary Shares (reduced shares -10.46%), (EBAY) eBay Inc (added shares +6.97%), (V) Visa Inc, CL-A (added shares +1.90%), (EL) Estee Lauder Companies Inc (added shares +1.57%) and (RACE) FERRARI NV (reduced shares -4.47%).
27 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Intercontinental Exchange Inc
|
new
|
$100.05
|
+47.96%($148.03)
|
2.31%
|
2020 Q3
|
≈ 0.25 years
|
||||
|
|
Thermo Fisher Scientific Inc
|
new
|
$441.52
|
+28.67%($568.09)
|
3.02%
|
2020 Q3
|
≈ 0.25 years
|
||||
|
|
Under Armour Inc A
|
new
|
$11.23
|
-39.40%($6.80)
|
1.78%
|
2020 Q3
|
≈ 0.25 years
|
||||
|
|
Nike Inc
|
+32.57%
|
$125.54
|
-66.81%($41.66)
|
4.65%
|
2016 Q4
|
≈ 4.00 years
|
||||
|
|
ALLEGION PLC
|
+29.72%
|
$98.91
|
+66.32%($164.51)
|
3.13%
|
2016 Q4
|
≈ 4.00 years
|
||||
|
|
Procter & Gamble Company
|
+14.04%
|
$138.99
|
+6.14%($147.53)
|
4.69%
|
2018 Q4
|
≈ 2.00 years
|
||||
|
|
Core Laboratories NV
|
+10.64%
|
$15.26
|
-26.48%($11.22)
|
0.35%
|
2020 Q2
|
≈ 0.50 years
|
||||
|
|
CHECK POINT SOFTWARE TECH
|
+10.33%
|
$120.34
|
+2.10%($122.86)
|
3.60%
|
2019 Q4
|
≈ 1.00 year
|
||||
|
|
Zoetis Inc
|
+7.10%
|
$165.37
|
-54.11%($75.88)
|
4.02%
|
2019 Q2
|
≈ 1.50 years
|
||||
|
|
Moodys Corp
|
+7.00%
|
$289.85
|
+66.70%($483.19)
|
2.60%
|
2016 Q4
|
≈ 4.00 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.